GUGGENHEIM CAPITAL LLC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 136 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$30,000
-99.2%
10,124
-94.7%
0.00%
-100.0%
Q2 2015$3,599,000
-60.1%
189,734
-45.0%
0.01%
-57.1%
Q1 2015$9,021,000
+252.9%
344,711
+182.4%
0.02%
+250.0%
Q4 2014$2,556,000
-16.1%
122,078
+33.7%
0.01%
-14.3%
Q3 2014$3,047,000
+6.5%
91,281
+2.4%
0.01%0.0%
Q2 2014$2,861,000
-33.3%
89,137
-4.1%
0.01%
-41.7%
Q1 2014$4,291,000
-13.7%
92,913
+32.6%
0.01%
-20.0%
Q4 2013$4,974,000
-4.8%
70,087
+15.0%
0.02%
-21.1%
Q3 2013$5,225,000
+53.7%
60,960
+13.6%
0.02%
+35.7%
Q2 2013$3,399,00053,6620.01%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
ADVENT INTERNATIONAL, L.P. 447,001$14,344,000100.00%
Broadfin Capital, LLC 1,620,088$51,988,0002.56%
SCOPIA CAPITAL MANAGEMENT LP 2,899,585$93,048,0002.40%
Tamarack Capital Management, LLC 400,000$11,656,0002.38%
March Altus Capital Management LP 199,037$6,387,0002.34%
PRICE MICHAEL F 240,000$7,702,0000.94%
DELTEC ASSET MANAGEMENT LLC 106,151$3,406,0000.72%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,207,598$102,932,0000.61%
CLOUGH CAPITAL PARTNERS L P 508,800$16,327,0000.52%
Catalyst Capital Advisors LLC 86,500$2,776,0000.45%
View complete list of AEGERION PHARMACEUTICALS INC shareholders